ReNeuron stem cell therapy shows positive long-term results in retinitis pigmentosa

ReNeuron’s hRPC stem cell therapy candidate has shown a meaningful clinical effect in patients with retinitis pigmentosa at 12 months, according to a press release.
Patients in a phase 2a segment of an ongoing phase 1/2 study who had a successful surgical procedure experienced a mean gain in visual acuity of 14.3 letters in the treated eye compared with 7 letters in the untreated eye at 12 months. Previous data showed a mean improvement of 12 letters at 9 months compared with –1 letter in the untreated eye.
“We remain (Read more...)

Full Story →